- Cancer News Coverage in Korean Newspapers: An Analytic Study in Terms of Cancer Awareness
-
Hye Sook Min, E Hwa Yun, Jinsil Park, Young Ae Kim
-
J Prev Med Public Health. 2020;53(2):126-134. Published online February 13, 2020
-
DOI: https://doi.org/10.3961/jpmph.19.256
-
-
4,171
View
-
117
Download
-
3
Crossref
-
 Abstract
Summary
 PDF
- Objectives
Cancer diagnoses have a tremendous impact on individuals and communities, drawing intense public concern. The objective of the current research was to examine news coverage and content related to cancer-related issues in Korean newspapers.
Methods
Primarily using the database system of the Korea Press Foundation, we conducted a content analysis of 2806 articles from 9 Korean daily newspapers during a recent 3-year period from 2015 to 2017. Thematic categories, the types of articles, attitudes and tone, and the number of sources in each article were coded and classified.
Results
Many news articles dealt with a diverse range of themes related to cancer, including general healthcare information, the latest research and development, specific medical institutions and personnel, and technology and products, which jointly accounted for 74.8% of all articles. Those thematic categories differed markedly in terms of article type, tone, and the number of cited sources. News articles provided extensive information about healthcare resources, and many articles seemed to contain advertising content. However, the content related to complex social issues such as National Health Insurance did not include enough information for the reader to contextualize the issues properly or present the issues systematically.
Conclusions
It can be assumed that the media exert differential influence on individuals through news coverage. Within the present reporting framework, the availability and usefulness of information are likely to depend solely on individuals’ capabilities, such as financial and health literacy; this dependency has a negative impact on knowledge gaps and health inequities.
-
Summary
Korean summary
암과 관련된 최근 3년간(2015년~2017년) 9개 전국 종합일간지의 보도를 한국언론재단 자료를 기반으로 조사 분석한 결과, 2,806개의 뉴스기사에서 일반적 암 정보, 최신 연구개발 소식, 병원 및 의료진 정보, 의료기기 및 신기술 정보 등 다양한 주제를 다루었다. 주제와 함께 기사 형태, 어조, 정보원을 분석한 결과, 암 관련 뉴스기사는 병원 및 의료진, 의료기기 및 신기술 정보를 중심으로 광고성 내용을 함께 포함하는 경우가 많았고, 건강보험 등 복합 분석이 필요한 주제에서는 심층적이고 포괄적인 분석이 드물고 내용을 단순화하는 경향이 있었다. 이러한 뉴스기사의 보도 틀은 암과 관련된 건강 및 질병 문제의 해결을 개인화하고 결과적으로 정보 격차 및 건강 불평등에 부정적 영향을 미칠 수 있다.
-
Citations
Citations to this article as recorded by  - Global research trends on precision oncology: A systematic review, bibliometrics, and visualized study
Baoyue Zhang, Bo Ao, Xinyue Lu, Shuang Yang, Pengfei Bao, Hongyun Wang, Ruifeng Li, Youliang Huang
Medicine.2022; 101(43): e31380. CrossRef - Calls to Action (Mobilizing Information) on Cancer in Online News: Content Analysis
Thomas Hongjie Zhang, Jen Sern Tham
Journal of Medical Internet Research.2021; 23(6): e26019. CrossRef - Newspaper representations of hand, foot and mouth disease (HFMD) and cancer in a Malaysian newspaper
Su-Hie Ting, Nursilah Kapiten
Communication and Medicine.2021; 17(1): 32. CrossRef
- The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea
-
Dongwoo Kim, Seok-Jun Yoon, Young-Hoon Gong, Young Ae Kim, Hye-Young Seo, Jihyun Yoon, A-Rim Kim
-
J Prev Med Public Health. 2015;48(4):180-187. Published online July 20, 2015
-
DOI: https://doi.org/10.3961/jpmph.15.022
-
-
9,825
View
-
115
Download
-
13
Crossref
-
Abstract
PDF
- Objectives
Metabolic syndrome is an important etiologic factor in the development of certain types of cancers. The economic cost of the treatment of cancer has been steadily increasing. We therefore estimated the economic burden of cancers attributable to metabolic syndrome in Korea.
Methods
We reviewed metabolic syndrome-related cancers and relative risk and then calculated population attributable fractions. We analyzed insurance claims data for metabolic syndrome-related cancers in 2012 in order to estimate the direct costs associated with these cancers, including hospitalization, outpatient visits, transportation costs, and caregivers’ costs as well as indirect costs such as loss of productivity due to cancer treatment and premature death.
Results
In 2012, 18 070 patients in Korea had cancers attributable to metabolic syndrome. The economic burden was USD 199.8 million and the direct and indirect costs were USD 124.5 million and USD 75.3 million, respectively.
Conclusions
We estimated the economic burden of cancers attributable to metabolic syndrome in Korea and the efforts are necessary to reduce this burden.
-
Summary
-
Citations
Citations to this article as recorded by
- Economic Burden of Colorectal Cancer in Korea
-
Ju-Young Byun, Seok-Jun Yoon, In-Hwan Oh, Young Ae Kim, Hye-Young Seo, Yo-Han Lee
-
J Prev Med Public Health. 2014;47(2):84-93. Published online March 31, 2014
-
DOI: https://doi.org/10.3961/jpmph.2014.47.2.84
-
-
15,247
View
-
148
Download
-
18
Crossref
-
Abstract
PDF
- Objectives
The incidence and survival rate of colorectal cancer in Korea are increasing because of improved screening, treatment technologies, and lifestyle changes. In this aging population, increases in economic cost result. This study was conducted to estimate the economic burden of colorectal cancer utilizing claims data from the Health Insurance Review and Assessment Service. MethodsEconomic burdens of colorectal cancer were estimated using prevalence data and patients were defined as those who received ambulatory treatment from medical institutions or who had been hospitalized due to colorectal cancer under the International Classification of Disease 10th revision codes from C18-C21. The economic burdens of colorectal cancer were calculated as direct costs and indirect costs. ResultsThe prevalence rate (per 100 000 people) of those who were treated for colorectal cancer during 2010 was 165.48. The economic burdens of colorectal cancer in 2010 were 3 trillion and 100 billion Korean won (KRW), respectively. Direct costs included 1 trillion and 960 billion KRW (62.85%), respectively and indirect costs were 1 trillion and 160 billion (37.15%), respectively. ConclusionsColorectal cancer has a large economic burden. Efforts should be made to reduce the economic burden of the disease through primary and secondary prevention.
-
Summary
-
Citations
Citations to this article as recorded by - Estimating the economic burden of colorectal cancer in China, 2019–2030: A population‐level prevalence‐based analysis
Hong Wang, Yan‐Jie Li, Lin Lei, Cheng‐Cheng Liu, Wan‐Qing Chen, Min Dai, Xin Wang, Jie‐Bin Lew, Ju‐Fang Shi, Ni Li, Jie He
Cancer Medicine.2024;[Epub] CrossRef - Relationship Between Aspirin Use and Site-Specific Colorectal Cancer Risk Among Individuals With Metabolic Comorbidity
Seokyung An, Madhawa Gunathilake, Jeonghee Lee, Minji Kim, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
Journal of Korean Medical Science.2024;[Epub] CrossRef - Cost of illness for colorectal cancer in Japan - a time trend and future projections (1996–2035) based on governmental statistics
Kunichika Matsumoto, Yosuke Hatakeyama, Kanako Seto, Ryo Onishi, Koki Hirata, Yinghui Wu, Tomonori Hasegawa
BMC Health Services Research.2023;[Epub] CrossRef - Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia
Bander Balkhi, Ahmed Alghamdi, Saeed Alqahtani, Marwan Al Najjar, Abdullah Al Harbi, Thamer Bin Traiki
Saudi Pharmaceutical Journal.2023; 31(11): 101822. CrossRef - A performance measurement framework for socially sustainable and resilient supply chains using environmental goods valuation methods
Aref A. Hervani, Santosh Nandi, Marilyn M. Helms, Joseph Sarkis
Sustainable Production and Consumption.2022; 30: 31. CrossRef - Direct medical costs of young-onset colorectal cancer: a worldwide systematic review
Ria Garg, Vicki Cheng, Ursula Ellis, Vanay Verma, Helen McTaggart-Cowan, Stuart Peacock, Jonathan M. Loree, Mohsen Sadatsafavi, Mary A. De Vera
BMC Health Services Research.2022;[Epub] CrossRef - Economic Burden of Colorectal Cancer: A Case of Fars, Iran
Abdosaleh Jafari, Peyman Mehdi Alamdarloo, Mehdi Dehghani, Peivand Bastani, Ramin Ravangard
Cancer Control.2021;[Epub] CrossRef - Quality of life and costs of patients prior to colorectal surgery
M. Pattamatta, B. J. J. Smeets, S. M. A. A. Evers, E. G. Peters, M. D. P. Luyer, M. Hiligsmann
Expert Review of Pharmacoeconomics & Outcomes Research.2020; 20(2): 193. CrossRef - Socioeconomic Burden of Cancer in Korea from 2011 to 2015
Young Ae Kim, Ye-Rin Lee, Jeongjoo Park, In-Hwan Oh, Hoseob Kim, Seok-Jun Yoon, Keeho Park
Cancer Research and Treatment.2020; 52(3): 896. CrossRef - The Direct and Indirect Costs of Colorectal Cancer in Vietnam: An Economic Analysis from a Social Perspective
Binh Thang Tran, Kui Son Choi, Thanh Xuan Nguyen, Dae Kyung Sohn, Sun-Young Kim, Jae Kyung Suh, Van Sang Phan, Huu Tri Pham, Minh Hanh Nguyen, Thanh Binh Nguyen, Huu Khoi Hoang, Thi Thanh Binh Nguyen, Minh Tu Nguyen, Jin-Kyoung Oh
International Journal of Environmental Research and Public Health.2020; 18(1): 12. CrossRef - Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study
In Cheol Hwang, Jooyoung Chang, Sang Min Park, Suminori Akiba
PLOS ONE.2017; 12(12): e0189114. CrossRef - Analysis of Productivity Costs in Cancer: A Systematic Review
Jordi Gol-Montserrat, María Luisa M. del Burgo, Luis Quecedo, Juan E. del Llano
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish.2017; 4(1): grhta.5000262. CrossRef - The Economic Burden of Hepatitis A, B, and C in South Korea
Changwoo Shon, Hyung-Yun Choi, Jae-Jun Shim, So-Youn Park, Kyung Suk Lee, Seok-Jun Yoon, In-Hwan Oh
Japanese Journal of Infectious Diseases.2016; 69(1): 18. CrossRef - Dehydroglyasperin D Inhibits the Proliferation of HT-29 Human Colorectal Cancer Cells Through Direct Interaction With Phosphatidylinositol 3-kinase
Sung Keun Jung, Chul-Ho Jeong
Journal of Cancer Prevention.2016; 21(1): 26. CrossRef - The Economic Burden of Cancer in Korea in 2009
So Young Kim, Jong-Hyock Park, Kyoung Hee Kang, Inuk Hwang, Hyung Kook Yang, Young-Joo Won, Hong-Gwan Seo, Dukhyoung Lee, Seok-Jun Yoon
Asian Pacific Journal of Cancer Prevention.2015; 16(3): 1295. CrossRef - The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea
Dongwoo Kim, Seok-Jun Yoon, Young-Hoon Gong, Young Ae Kim, Hye-Young Seo, Jihyun Yoon, A-Rim Kim
Journal of Preventive Medicine and Public Health.2015; 48(4): 180. CrossRef - Trends in Colorectal Cancer Incidence in Daejeon and Chungcheongnam-do, South Korea (2000-2012)
Soon-Young Kim, In-Sun Kweon, Jung-A Kim, Tae-Yong Lee, Hae-Sung Nam
Journal of agricultural medicine and community health.2015; 40(3): 115. CrossRef - FOXM1-mediated downregulation of uPA and MMP9 by 3,3′-diindolylmethane inhibits migration and invasion of human colorectal cancer cells
HUA JIN, XIU JUAN LI, MAN HEE PARK, SOO MI KIM
Oncology Reports.2015; 33(6): 3171. CrossRef
- The Economic Burden of Epilepsy in Korea, 2010
-
Jaehun Jung, Hye-Young Seo, Young Ae Kim, In-Hwan Oh, Yo Han Lee, Seok-Jun Yoon
-
J Prev Med Public Health. 2013;46(6):293-299. Published online November 28, 2013
-
DOI: https://doi.org/10.3961/jpmph.2013.46.6.293
-
-
10,450
View
-
130
Download
-
11
Crossref
-
Abstract
PDF
- Objectives
The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010. MethodsThis study used a prevalence based approach to calculate the cost of epilepsy. Claims data from the Korean national health insurance and data from the Korea health panel, the Korea National Statistical Office's records of causes of death, and labor statistics were used to estimate the cost of epilepsy. Patients were defined as those who were hospitalized or visited an outpatient clinic during 2010 with a diagnosis of epilepsy (International Classification of Diseases 10th revision codes G40-G41). Total costs of epilepsy included direct medical costs, direct non-medical cost and indirect costs. ResultsThe annual prevalence of treated epilepsy was 228 per 100 000 population, and higher in men. The age-specific prevalence was highest for teenagers. The total economic burden of epilepsy was 536 billion Korean won (KW). Indirect cost (304 billion KW) was 1.3 times greater than direct cost (232 billion KW). By gender, the male (347 billion KW) were more burdened than the female (189 billion KW). The estimated cost in young age younger than 20 years old was 24.5% of the total burden of epilepsy. ConclusionsA significant portion of the economic burden of epilepsy is borne by people in young age. To reduce the economic burden of epilepsy, effective prevention and treatment strategies are needed.
-
Summary
-
Citations
Citations to this article as recorded by - Economic assessment of convulsive status epilepticus: Investigating socioeconomic correlations in hospitalization costs and outcomes in Northern India
Ahmad Ghayas Ansari, Ariba Nasar, Hiba Nasar
IP Indian Journal of Neurosciences.2024; 10(2): 78. CrossRef - Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: A nationwide cohort study in South Korea
Ji Woong Lee, Jung-Ae Kim, Min Young Kim, Sang Kun Lee
Epilepsy & Behavior.2022; 126: 108459. CrossRef - Cost of Illness of Epilepsy and Associated Factors in Patients Attending Adult Outpatient Department of University of Gondar Referral Hospital, Northwest Ethiopia
Piniel Melkamu, Yaregal Animut, Amare Minyihun, Asmamaw Atnafu, Mezgebu Yitayal
Risk Management and Healthcare Policy.2021; Volume 14: 2385. CrossRef - Cost–benefit analysis, cost-effectiveness analysis, and impact of antiepileptic drugs on the risk of fracture in patients with epilepsy: A nationwide cohort study
Hsin-Hsuan Cheng, Pei-Tseng Kung, Bo-Ren Wang, Li-Ting Chiu, Wen-Chen Tsai
Epilepsy & Behavior.2020; 103: 106851. CrossRef - Introducing big data analysis using data from National Health Insurance Service
EunJin Ahn
Korean Journal of Anesthesiology.2020; 73(3): 205. CrossRef - Epilepsy in Asia: Disease burden, management barriers, and challenges
Eugen Trinka, Patrick Kwan, ByungIn Lee, Amitabh Dash
Epilepsia.2019; 60(S1): 7. CrossRef - The Present and Future of Vagus Nerve Stimulation
Jeyul Yang, Ji Hoon Phi
Journal of Korean Neurosurgical Society.2019; 62(3): 344. CrossRef - Costs of informal nursing care for patients with neurologic disorders
Freya Diederich, Hans-Helmut König, Claudia Mietzner, Christian Brettschneider
Neurology.2018; 90(1): 28. CrossRef - The Economic Burden of Hepatitis A, B, and C in South Korea
Changwoo Shon, Hyung-Yun Choi, Jae-Jun Shim, So-Youn Park, Kyung Suk Lee, Seok-Jun Yoon, In-Hwan Oh
Japanese Journal of Infectious Diseases.2016; 69(1): 18. CrossRef - A nationwide epidemiological study of newly diagnosed spine metastasis in the adult Korean population
Seil Sohn, Jinhee Kim, Chun Kee Chung, Na Rae Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn, Sung Hwan Kim
The Spine Journal.2016; 16(8): 937. CrossRef - The direct costs of epilepsy in Russia. A prospective cost-of-illness study from a single center in Moscow
Alla Guekht, Maria Mizinova, Igor Kaimovsky, Oksana Danilenko, Elisa Bianchi, Ettore Beghi
Epilepsy & Behavior.2016; 64: 122. CrossRef
- A Strategy Toward Reconstructing the Healthcare System of a Unified Korea
-
Yo Han Lee, Seok-Jun Yoon, Seok Hyang Kim, Hyun-Woung Shin, Jin Yong Lee, Beomsoo Kim, Young Ae Kim, Jangho Yoon, Young Seok Shin
-
J Prev Med Public Health. 2013;46(3):134-138. Published online May 31, 2013
-
DOI: https://doi.org/10.3961/jpmph.2013.46.3.134
-
-
8,591
View
-
111
Download
-
3
Crossref
-
Abstract
PDF
This road map aims to establish a stable and integrated healthcare system for the Korean Peninsula by improving health conditions and building a foundation for healthcare in North Korea through a series of effective healthcare programs. With a basic time frame extending from the present in stages towards unification, the roadmap is composed of four successive phases. The first and second phases, each expected to last five years, respectively, focus on disease treatment and nutritional treatment. These phases would thereby safeguard the health of the most vulnerable populations in North Korea, while fulfilling the basic health needs of other groups by modernizing existing medical facilities. Based on the gains of the first two phases, the third phase, for ten years, would prepare for unification of the Koreas by promoting the health of all the North Korean people and improving basic infrastructural elements such as health workforce capacity and medical institutions. The fourth phase, assuming that unification will take place, provides fundamental principles and directions for establishing an integrated healthcare system across the Korean Peninsula. We are hoping to increase the consistency of the program and overcome several existing concerns of the current program with this roadmap. -
Summary
-
Citations
Citations to this article as recorded by - Non-Communicable Diseases and Transitioning Health System in the Democratic People’s Republic of Korea during COVID-19 Lockdown
Jin-Won Noh, Kyoung-Beom Kim, Ha-Eun Jang, Min-Hee Heo, Young-Jin Kim, Jiho Cha
Healthcare.2022; 10(10): 2095. CrossRef - Systematic review of evidence on public health in the Democratic People’s Republic of Korea
John J Park, Ah-Young Lim, Hyung-Soon Ahn, Andrew I Kim, Soyoung Choi, David HW Oh, Owen Lee-Park, Sharon Y Kim, Sun Jae Jung, Jesse B Bump, Rifat Atun, Hee Young Shin, Kee B Park
BMJ Global Health.2019; 4(2): e001133. CrossRef - Awareness of Korean Unification and Health Care in Healthcare Professional Students
Kyung Jin Jang, Yoon Ki Seoung, Su Hyun Yoon, Hye Seung Chumg, Soo Hyang Kim, You Lee Yang, Sang Hui Chu
Journal of Korean Public Health Nursing.2016; 30(3): 456. CrossRef
- Overview of the Burden of Diseases in North Korea
-
Yo Han Lee, Seok-Jun Yoon, Young Ae Kim, Ji Won Yeom, In-Hwan Oh
-
J Prev Med Public Health. 2013;46(3):111-117. Published online May 31, 2013
-
DOI: https://doi.org/10.3961/jpmph.2013.46.3.111
-
-
22,816
View
-
164
Download
-
20
Crossref
-
Abstract
PDF
This article evaluates the overall current disease burden of North Korea through the recent databases of international organizations. It is notable that North Korea as a nation is exhibiting a relatively low burden from deaths and that there is greater burden from deaths caused by non-communicable diseases than from those caused by communicable diseases and malnutrition. However, the absolute magnitude of problems from communicable diseases like TB and from child malnutrition, which will increase the disease burden in the future, remains great. North Korea, which needs to handle both communicable and nutritional conditions, and non-communicable diseases, whose burden is ever more increasing in the nation, can now be understood as a country with the 'double-burden' of disease. -
Summary
-
Citations
Citations to this article as recorded by - Understanding pediatric surgical needs in North Korea: a modeling analysis
Phillip J Hsu, Sangchul Yoon, Kee B Park
World Journal of Pediatric Surgery.2024; 7(1): e000697. CrossRef - The Possible Impact of Nationwide Vaccination on Outcomes of the COVID-19 Epidemic in North Korea: A Modelling Study
Sung-mok Jung, Jaehun Jung
Journal of Korean Medical Science.2022;[Epub] CrossRef - Trends and patterns of North Korea’s disease burden from 1990 to 2019: Results from Global Burden of Disease study 2019
Eun Hae Lee, Minjae Choi, Joshua Kirabo Sempungu, Yo Han Lee, Negar Rezaei
PLOS ONE.2022; 17(11): e0277335. CrossRef - Non-Communicable Diseases and Transitioning Health System in the Democratic People’s Republic of Korea during COVID-19 Lockdown
Jin-Won Noh, Kyoung-Beom Kim, Ha-Eun Jang, Min-Hee Heo, Young-Jin Kim, Jiho Cha
Healthcare.2022; 10(10): 2095. CrossRef - Prediction of cardiovascular diseases mortality- and disability-adjusted life-years attributed to modifiable dietary risk factors from 1990 to 2030 among East Asian countries and the world
Nawsherwan, Wang Bin, Zhang Le, Sumaira Mubarik, Guo Fu, Yan Wang
Frontiers in Nutrition.2022;[Epub] CrossRef - Trend of Disease Burden of North Korean Defectors in South Korea Using Disability-adjusted Life Years from 2010 to 2018
Keun A Kim, Yoon-Sun Jung, Chae-Bong Kim, Ki-Beom Kim, Seok-Jun Yoon
Journal of Korean Medical Science.2021;[Epub] CrossRef - Global estimated Disability-Adjusted Life-Years (DALYs) of diarrheal diseases: A systematic analysis of data from 28 years of the global burden of disease study
Natacha U. Karambizi, Christopher S. McMahan, Carl N. Blue, Lesly A. Temesvari, Srinivas Goli
PLOS ONE.2021; 16(10): e0259077. CrossRef - Surgical Diseases in North Korea: An Overview of North Korean Medical Journals
Sejin Choi, Taehoon Kim, Soyoung Choi, Hee Young Shin
International Journal of Environmental Research and Public Health.2020; 17(24): 9346. CrossRef - Perceptions of the Osteopathic Profession in New York City's Korean Communities
Justin Chin, DO, Haeinn Woo, OMS-IV, Diane Choi, OMS-III, Emily Dube, MS, Mikhail Volokitin, MD, DO, Christine Lomiguen, MD
Osteopathic Family Physician.2020; 13(1): 12. CrossRef - Epidemiology survey of infectious diseases in North Korean travelers, 2015–2017
Pengyu Han, Yanxia Teng, Xiuxin Bi, Jinge Li, Dianxing Sun
BMC Infectious Diseases.2019;[Epub] CrossRef - Underestimated Burden: Non-Communicable Diseases in North Korea
Shin Ha, Yo Han Lee
Yonsei Medical Journal.2019; 60(5): 481. CrossRef - Frequently covered diseases in North Korean internal medicine journal Internal Medicine [Naegwa]—Secondary publication
Shin Ha, Yo Han Lee
Science Editing.2019; 6(2): 99. CrossRef - Infectious disease risks among refugees from North Korea
Hiroshi Nishiura, Hyojung Lee, Baoyin Yuan, Akira Endo, Andrei R. Akhmetzhanov, Gerardo Chowell
International Journal of Infectious Diseases.2018; 66: 22. CrossRef - The life expectancy gap between North and South Korea from 1993 to 2008
Jinwook Bahk, Majid Ezzati, Young-Ho Khang
European Journal of Public Health.2018; 28(5): 830. CrossRef - The Status and Distinct Characteristics of Endocrine Diseases in North Korean Articles Published between 2006 and 2015
Kyeong Jin Kim, Shin Ha, Yo Han Lee, Jung Hyun Noh, Sin Gon Kim
Endocrinology and Metabolism.2018; 33(2): 268. CrossRef - A Program to Treat Hepatitis B in North Korea: A Model of Antiviral Therapy in a Resource-Poor Setting
Alice Unah Lee, Heidi Linton, Marcia Kilsby, David C. Hilmers
Gut and Liver.2018; 12(6): 615. CrossRef - Fighting Hepatitis B in North Korea: Feasibility of a Bi-modal Prevention Strategy
Markus Unnewehr, August Stich
Journal of Korean Medical Science.2015; 30(11): 1584. CrossRef - The social and political construction of health-care systems – historical observations from selected countries in Asia
John Grundy, Elizabeth Hoban, Steve Allender
Health Systems.2015; 4(2): 124. CrossRef - Public Health and International Partnerships in the Democratic People’s Republic of Korea
John Grundy, Beverley-Ann Biggs, David B. Hipgrave
PLOS Medicine.2015; 12(12): e1001929. CrossRef - North Korea: a challenge for global solidarity
Espen Bjertness, Ahmed Ali Madar
The Lancet.2014; 383(9926): 1381. CrossRef
- Impact of Changes in Maternal Age and Parity Distribution on Low Birth Weight Incidence Rate.
-
Young Ae Kim, Jung Han Park
-
Korean J Prev Med. 1989;22(2):276-282.
-
-
-
Abstract
PDF
- The objective of this study was to examine the impact of changes in maternal age and parity distribution on birth weight. The study population included 7,786 single live births in 1987 delivered at 9 medical facilities in Pusan. Data were obtained from the delivery record. The proportion of infants born to the mothers of 25-29 years increased from 56.4% in 1977 to 65.1% in 1987 and the proportion to the mothers of 30-34 years increased from 18.8% in 1977 to 21.6% in 1987. In the same period, the proportions of 1st and 2nd birth order were increased from 56.9% and 28.8% to 59.9% and 36.8%, respectively. The proportion of infants born to the age group of < or = 24 and 35 < or = years were decreased in 1987. The proportion of births of the third or higher birth order was decreased from 14.2% in 1977 to 3.3% in 1987. Low birth weight (<2500gm) incidence rate was 5.3% in 1977 and it was decreased to 4.0% in 1987. It was estimated that changes in maternal age-parity distribution accounted for 10.7% of the decreased in low birth weight incidence rate. Rest of the change (89.3%) was attributed to the reduction of age-parity specific low birth weight incidence rate. Application of the direct adjustment method was considered to be an adequate tool for evaluating the impact of family planning on neonatal health.
-
Summary
|
KSPM
